Alkermes Inc. plc

ALKSNASDAQUSD
37.29 USD
0.19 (0.50%)🟢LIVE (AS OF 01:40 PM EDT)
🟢Market: OPEN
Open?$38.02
High?$38.43
Low?$35.01
Prev. Close?$37.48
Volume?821.4K
Avg. Volume?2.1M
VWAP?$37.38
Rel. Volume?0.40x
Bid / Ask
Bid?$32.28 × 100
Ask?$37.49 × 200
Spread?$5.21
Midpoint?$34.89
Valuation & Ratios
Market Cap?6.2B
Shares Out?166.7M
Float?162.4M
Float %?98.4%
P/E Ratio?40.90
P/B Ratio?3.57
EPS?$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
6.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.27Strong
Quick Ratio?1.70Adequate
Cash Ratio?0.59Adequate
Debt/Equity?0.86Moderate
ValuationFAIRLY VALUED
Score
56/100
P/E?
40.9PRICEY
P/B?
3.57FAIR
P/S?
4.00FAIR
P/FCF?
28.2FAIR
EV/EBITDA?
32.1HIGH
EV/Sales?
4.74FAIR
Returns & Efficiency
ROE?
8.7%FAIR
ROA?
3.6%FAIR
Cash Flow & Enterprise
FCF?$221.8M
Enterprise Value?$7.4B
Fundamentals ratios updated end of day